SOCS1 Is a Critical Inhibitor of Interferon γ Signaling and Prevents the Potentially Fatal Neonatal Actions of this Cytokine

作者: Warren S Alexander , Robyn Starr , Jennifer E Fenner , Clare L Scott , Emanuela Handman

DOI: 10.1016/S0092-8674(00)80047-1

关键词:

摘要: Mice lacking suppressor of cytokine signaling-1 (SOCS1) develop a complex fatal neonatal disease. In this study, SOCS1-/- mice were shown to exhibit excessive responses typical those induced by interferon gamma (IFNgamma), hyperresponsive viral infection, and yielded macrophages with an enhanced IFNgamma-dependent capacity kill L. major parasites. The disease in was prevented administration anti-IFNgamma antibodies did not occur also the IFNgamma gene. Although is essential for resistance variety infections, potential toxic action IFNgamma, particularly mice, appears require regulation. Our data indicate that SOCS1 key modulator action, allowing protective effects without risk associated pathological responses.

参考文章(67)
Erika A. Bach, Michel Aguet, Robert D. Schreiber, THE IFNγ RECEPTOR:A Paradigm for Cytokine Receptor Signaling Annual Review of Immunology. ,vol. 15, pp. 563- 591 ,(1997) , 10.1146/ANNUREV.IMMUNOL.15.1.563
Melanie J. Newport, Clare M. Huxley, Sara Huston, Catherine M. Hawrylowicz, Ben A. Oostra, Robert Williamson, Michael Levin, A MUTATION IN THE INTERFERON GAMMA-RECEPTOR GENE AND SUSCEPTIBILITY TO MYCOBACTERIAL INFECTION The New England Journal of Medicine. ,vol. 335, pp. 1941- 1949 ,(1996) , 10.1056/NEJM199612263352602
C. Schindler, J. E. Darnell, Transcriptional Responses to Polypeptide Ligands: The JAK-STAT Pathway Annual Review of Biochemistry. ,vol. 64, pp. 621- 652 ,(1995) , 10.1146/ANNUREV.BI.64.070195.003201
Seth J. Corey, Steven M. Anderson, Src-related protein tyrosine kinases in hematopoiesis Blood. ,vol. 93, pp. 1- 14 ,(1999) , 10.1182/BLOOD.V93.1.1.401A45_1_14
Jan Tavernier, Walter Fiers, Chantal Maury, Ion Gresser, David Woodrow, Jill Moss, Toxic effects of recombinant tumor necrosis factor in suckling mice. Comparisons with interferon alpha/beta. American Journal of Pathology. ,vol. 128, pp. 13- 18 ,(1987)
R. J. Tatake, R. A. Zeff, Regulated Expression of the Major Histocompatibility Complex Class I Genes Experimental Biology and Medicine. ,vol. 203, pp. 405- 417 ,(1993) , 10.3181/00379727-203-43616A
D Metcalf, WS Alexander, AG Elefanty, NA Nicola, DJ Hilton, R Starr, S Mifsud, L Di Rago, Aberrant hematopoiesis in mice with inactivation of the gene encoding SOCS-1 Leukemia. ,vol. 13, pp. 926- 934 ,(1999) , 10.1038/SJ.LEU.2401440
Alfons Billiau, Interferon-gamma: biology and role in pathogenesis. Advances in Immunology. ,vol. 62, pp. 61- 130 ,(1996) , 10.1016/S0065-2776(08)60428-9
KEIKO OZATO, NANCI M. MAYER, DAVID H. SACHS, Monoclonal antibodies to mouse major histocompatibility complex antigens. Transplantation. ,vol. 34, pp. 113- 120 ,(1982) , 10.1097/00007890-198209000-00001